MedPath

A clinical study to compare the efficacy of add-on Ayurveda treatment versus Allopathy treatment in Schizophrenia.

Phase 4
Conditions
Health Condition 1: F20- Schizophrenia
Registration Number
CTRI/2023/02/050158
Lead Sponsor
Ministry of AYUSH, Government of India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Diagnosed patients of Unmada according to Ayurveda.

2. Patients of Schizophrenia spectrum disorders as per DSM-5.

3. Patients who have partially responded to treatment with residual symptoms and predominant cognitive symptoms.

4. Patients on stable medications for at least 8 weeks.

5. Patients of both sexes in the age group of 18 to 60 years, irrespective of socioeconomic status.

6. Patients ready to sign the informed consent form.

7. Right handedness

Exclusion Criteria

1. Patients with suicidal tendencies/ thoughts.

2. Patients with psychosis other than schizophrenia

3. Patients with neurotic disorders like Anxiety, OCD, Depression, PTSD.

4. Patients having cardiovascular problems.

5. Patients with neurological disorders such as any significant head injury.

6. Patients with neurodegenerative disorders.

7. Patients of substance use disorders.

8. Pregnant and lactating women.

9. Patients with uncontrolled Type 2 Diabetes mellitus

10. Patients on β-blockers, thiazide diuretics, corticosteroids, HRT.

11. Patients with Uncontrolled Blood pressure.

12. Patients with concurrent Hepatic Dysfunction

13. Patients with Renal Dysfunction Patients with severe Pulmonary Dysfunction

14. Patients with evidence of malignancy

15. Patients suffering from major systemic illness necessitating long-term drug treatment.

16. Patients who have completed participation in any other clinical trial during the past six (06) months.

17. Left-handedness

18. Education level is less than 8th grade.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath